These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36541799)

  • 61. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.
    Im SJ; Hashimoto M; Gerner MY; Lee J; Kissick HT; Burger MC; Shan Q; Hale JS; Lee J; Nasti TH; Sharpe AH; Freeman GJ; Germain RN; Nakaya HI; Xue HH; Ahmed R
    Nature; 2016 Sep; 537(7620):417-421. PubMed ID: 27501248
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-lived memory CD8+ T cells are programmed by prolonged antigen exposure and low levels of cellular activation.
    Bachmann MF; Beerli RR; Agnellini P; Wolint P; Schwarz K; Oxenius A
    Eur J Immunol; 2006 Apr; 36(4):842-54. PubMed ID: 16552716
    [TBL] [Abstract][Full Text] [Related]  

  • 63. IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells.
    van Leeuwen EM; de Bree GJ; Remmerswaal EB; Yong SL; Tesselaar K; ten Berge IJ; van Lier RA
    Blood; 2005 Sep; 106(6):2091-8. PubMed ID: 15947093
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung.
    Chen HD; Fraire AE; Joris I; Brehm MA; Welsh RM; Selin LK
    Nat Immunol; 2001 Nov; 2(11):1067-76. PubMed ID: 11668342
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.
    Belnoue E; Fontannaz-Bozzotti P; Grillet S; Lambert PH; Siegrist CA
    J Virol; 2007 Jul; 81(14):7338-50. PubMed ID: 17494081
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phenotypic and Functional Alterations in Circulating Memory CD8 T Cells with Time after Primary Infection.
    Martin MD; Kim MT; Shan Q; Sompallae R; Xue HH; Harty JT; Badovinac VP
    PLoS Pathog; 2015 Oct; 11(10):e1005219. PubMed ID: 26485703
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of tumor necrosis factor receptors in regulating CD8 T-cell responses during acute lymphocytic choriomeningitis virus infection.
    Suresh M; Singh A; Fischer C
    J Virol; 2005 Jan; 79(1):202-13. PubMed ID: 15596816
    [TBL] [Abstract][Full Text] [Related]  

  • 68. STAT5 is critical to maintain effector CD8+ T cell responses.
    Tripathi P; Kurtulus S; Wojciechowski S; Sholl A; Hoebe K; Morris SC; Finkelman FD; Grimes HL; Hildeman DA
    J Immunol; 2010 Aug; 185(4):2116-24. PubMed ID: 20644163
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CD40L expression by CD4
    Durlanik S; Loyal L; Stark R; Sercan Alp Ö; Hartung A; Radbruch A; von Herrath M; Matzmohr N; Frentsch M; Thiel A
    Eur J Immunol; 2016 Nov; 46(11):2566-2573. PubMed ID: 27562840
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Formation of IL-7Ralphahigh and IL-7Ralphalow CD8 T cells during infection is regulated by the opposing functions of GABPalpha and Gfi-1.
    Chandele A; Joshi NS; Zhu J; Paul WE; Leonard WJ; Kaech SM
    J Immunol; 2008 Apr; 180(8):5309-19. PubMed ID: 18390712
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antiviral memory CD8 T-cell differentiation, maintenance, and secondary expansion occur independently of MyD88.
    Rahman AH; Zhang R; Blosser CD; Hou B; Defranco AL; Maltzman JS; Wherry EJ; Turka LA
    Blood; 2011 Mar; 117(11):3123-30. PubMed ID: 21233312
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of PKR and Type I IFNs in viral control during primary and secondary infection.
    Nakayama Y; Plisch EH; Sullivan J; Thomas C; Czuprynski CJ; Williams BR; Suresh M
    PLoS Pathog; 2010 Jun; 6(6):e1000966. PubMed ID: 20585572
    [TBL] [Abstract][Full Text] [Related]  

  • 73. MyD88 plays a critical T cell-intrinsic role in supporting CD8 T cell expansion during acute lymphocytic choriomeningitis virus infection.
    Rahman AH; Cui W; Larosa DF; Taylor DK; Zhang J; Goldstein DR; Wherry EJ; Kaech SM; Turka LA
    J Immunol; 2008 Sep; 181(6):3804-10. PubMed ID: 18768833
    [TBL] [Abstract][Full Text] [Related]  

  • 74. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
    Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination.
    Tan JT; Whitmire JK; Murali-Krishna K; Ahmed R; Altman JD; Mittler RS; Sette A; Pearson TC; Larsen CP
    J Immunol; 2000 Mar; 164(5):2320-5. PubMed ID: 10679066
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CD8 T cell memory in B cell-deficient mice.
    Asano MS; Ahmed R
    J Exp Med; 1996 May; 183(5):2165-74. PubMed ID: 8642326
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.
    Holst PJ; Christensen JP; Thomsen AR
    J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeting of non-dominant antigens as a vaccine strategy to broaden T-cell responses during chronic viral infection.
    Holst PJ; Jensen BA; Ragonnaud E; Thomsen AR; Christensen JP
    PLoS One; 2015; 10(2):e0117242. PubMed ID: 25679375
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CD70 deficiency impairs effector CD8 T cell generation and viral clearance but is dispensable for the recall response to lymphocytic choriomeningitis virus.
    Munitic I; Kuka M; Allam A; Scoville JP; Ashwell JD
    J Immunol; 2013 Feb; 190(3):1169-79. PubMed ID: 23269247
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibitory signaling sustains a distinct early memory CD8
    Johnnidis JB; Muroyama Y; Ngiow SF; Chen Z; Manne S; Cai Z; Song S; Platt JM; Schenkel JM; Abdel-Hakeem M; Beltra JC; Greenplate AR; Ali MA; Nzingha K; Giles JR; Harly C; Attanasio J; Pauken KE; Bengsch B; Paley MA; Tomov VT; Kurachi M; Vignali DAA; Sharpe AH; Reiner SL; Bhandoola A; Johnson FB; Wherry EJ
    Sci Immunol; 2021 Jan; 6(55):. PubMed ID: 33452106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.